HEALTH ECONOMIC EVALUATION OF REPLACING PCV13 WITH PCV15 IN THE DANISH CHILDHOOD VACCINATION PROGRAMME

被引：0
|
作者：
Kantso, Roesgaard L. [1 ]
Pedersen, M. [2 ]
Leth, S. [3 ]
Huang, M. [4 ]
Vinfeldt, M. [1 ]
机构：
[1] MSD Denmark, Copenhagen, Denmark
[2] Incentive, Odense SV, Denmark
[3] MSD Denmark, Copenhagen, Denmark
[4] Merck & Co Inc, Rahway, NJ 07065 USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE24
引用
收藏
页码：S57 / S57
页数：1
相关论文
共 50 条
  • [1] PUBLIC HEALTH IMPACT AND COST-EFFECTIVENESS OF REPLACING PCV13 WITH PCV15 IN THE NATIONAL IMMUNIZATION PROGRAM IN SAUDI ARABIA
    Huang, M.
    Weaver, J.
    Albassam, G.
    Akel, R.
    Chhabra, N.
    Ranjan, S.
    Gupta, S.
    Ugrekhelidze, D.
    VALUE IN HEALTH, 2024, 27 (12)
  • [2] COST-EFFECTIVENESS ANALYSIS OF REPLACING PCV13 WITH PCV15 IN THE PEDIATRIC NATIONAL IMMUNIZATION PROGRAM OF GREECE
    Gountas, I
    Yfantopoulos, N.
    Trimis, G.
    Boutselakou, E.
    Poughias, L.
    Karokis, A.
    VALUE IN HEALTH, 2023, 26 (12) : S136 - S137
  • [3] Switch in a childhood pneumococcal vaccination programme from PCV13 to PCV10: a defendable approach?
    Desmet, Stefanie
    Verhaegen, Jan
    Van Ranst, Marc
    Peetermans, Willy
    Lagrou, Katrien
    LANCET INFECTIOUS DISEASES, 2018, 18 (08): : 830 - 831
  • [4] Interpretation of the switch in a childhood pneumococcal vaccination programme from PCV13 to PCV10 in Belgium
    Izurieta, Patricia
    Breuer, Thomas
    LANCET INFECTIOUS DISEASES, 2018, 18 (08): : 831 - 832
  • [5] Effect on nasopharyngeal pneumococcal carriage of replacing PCV7 with PCV13 in the Expanded Programme of Immunization in The Gambia
    Roca, Anna
    Bojang, Abdoulie
    Bottomley, Christian
    Gladstone, Rebecca A.
    Adetifa, Jane U.
    Egere, Uzochukwu
    Burr, Sarah
    Antonio, Martin
    Bentley, Stephen
    Kampmann, Beate
    Oluwalana, Claire
    Idoko, Olubukola
    Cox, Isatou
    Kwambana-Adams, Brenda A.
    Jarju, Sheikh
    Foster-Nyarko, Ebenezer
    Greenwood, Brian
    VACCINE, 2015, 33 (51) : 7144 - 7151
  • [6] Comparison of pneumococcal immunogenicity elicited by the PCV13 and PCV15 vaccines in adults 18 through 49 years of age
    Kanevsky, Isis
    Surendran, Naveen
    McElwee, Kathleen
    Lei, Lanyu
    Watson, Wendy
    Pride, Michael
    Scully, Ingrid
    Karauzum, Hatice
    Anderson, Annaliesa
    Young, Mariano
    VACCINE, 2023, 41 (45) : 6625 - 6629
  • [7] The Health and Economic Effects of PCV15 and PCV20 During the First Year of Life in the US
    Ilic, Aleksandar
    Tort, Maria J.
    Cane, Alejandro
    Farkouh, Raymond A.
    Rozenbaum, Mark H.
    VACCINES, 2024, 12 (11)
  • [8] Impact of PCV13 vaccination in Blantyre, Malawi
    Kamthunzi, Portia
    LANCET GLOBAL HEALTH, 2021, 9 (07): : 893 - 894
  • [9] Comparing the effect of PCV10 and PCV13 paediatric vaccination programmes
    Theilacker, Christian
    Fletcher, Mark A.
    Spinardi, Julia R.
    Jodar, Luis
    Gessner, Bradford D.
    LANCET INFECTIOUS DISEASES, 2021, 21 (02): : 170 - 171
  • [10] Comparing the effect of PCV10 and PCV13 paediatric vaccination programmes Reply
    Agudelo, Clara Ines
    Castaneda-Orjuela, Carlos
    Di Fabio, Jose Luis
    Castaneda, Elizabeth
    LANCET INFECTIOUS DISEASES, 2021, 21 (02): : 171 - 172
12345